Quality of life and mental health in breast cancer survivors compared with non-cancer controls: a study of patient-reported outcomes in the United Kingdom
Authors:
Open Access
- 21 October 2020
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Survivorship
- Vol. 15 (4) , 564-575
Abstract
Purpose: There is limited high-quality evidence on quality of life, anxiety, and depressive symptoms in breast cancer survivors and women with no history of cancer. We aimed to address this by comparing patient-reported outcomes between breast cancer survivors and women with no history of breast cancer. Methods: Breast cancer survivors and women with no prior cancer were selected from the UK Clinical Practice Research Datalink GOLD primary care database, which includes population-based primary care electronic health record data. Breast cancer survivors and controls were frequency matched by age and primary care practice. Outcomes were assessed with validated instruments via postal questionnaire. Linear and logistic regression models were fitted to estimate adjusted associations between breast cancer survivorship and outcomes. Results: A total of 356 breast cancer survivors (8.1 years post diagnosis) and 252 women with no prior cancer participated in the study. Compared with non-cancer controls, breast cancer survivors had poorer QoL in the domains of cognitive problems (adjusted β (aβ) = 1.4, p = 0.01), sexual function (aβ = 1.7, p = 0.02) and fatigue (aβ = 1.3, p = 0.01), but no difference in negative feelings, positive feelings, pain, or social avoidance. Breast cancer survivors had higher odds of borderline-probable anxiety (score ≥ 8) (adjusted OR = 1.47, 95%CI:1.15–1.87), but no differences in depression. Advanced stage at diagnosis and chemotherapy treatment were associated with poorer QoL. Conclusions: Compared with women with no history of cancer, breast cancer survivors report more problems with cognition, sexual function, fatigue, and anxiety, particularly where their cancer was advanced and/or treated with chemotherapy. Implications for Cancer Survivors: Breast cancer survivors with more advanced disease and/or treated with chemotherapy should be closely monitored and, when possible, offered evidence-based intervention for fatigue, cognitive dysfunction, and sexual problems.Keywords
Funding Information
- Wellcome Trust (107731/Z/15/Z)
- Royal Society (107731/Z/15/Z)
- Medical Research Council (MR/M016234/1)
This publication has 46 references indexed in Scilit:
- Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: a cross-sectional surveyBMJ Open, 2013
- A systematic review of quality of life instruments in long-term breast cancer survivorsHealth and Quality of Life Outcomes, 2012
- Patient experiences with communication about sex during and after treatment for cancerPsycho-Oncology, 2011
- Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studiesThe Lancet Oncology, 2011
- Evaluation of screening instruments for depression and anxiety in breast cancer survivorsBreast Cancer Research and Treatment, 2009
- Lymphedema and Quality of Life in Breast Cancer Survivors: The Iowa Women's Health StudyJournal of Clinical Oncology, 2008
- Health-related quality of life 18 months after breast cancer: comparison with the general population of Queensland, AustraliaSupportive Care in Cancer, 2008
- Body image and sexual problems in young women with breast cancerPsycho-Oncology, 2005
- Study of Sexual Functioning Determinants in Breast Cancer SurvivorsThe Breast Journal, 2005
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983